Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards

Charles Schwab Chief Fixed Income Strategist Kathy Jones Talks Treasuries and Fed Interest Rates
07:39

President and CEO of Stew Leonard's, Steward Leonard Jr., Talks Consumer Spending and War Impact
06:06

Democratic Senator Gary Peters of Michigan Talks Pentagon Funding, Rising Gas Prices
11:20